- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT00572520
Effectiveness of Behavioral Treatments for Obesity and Major Depression in Women
Treating Co-morbid Obesity and Major Depressive Disorder
Aperçu de l'étude
Statut
Les conditions
Description détaillée
Obesity is one of the most alarming current health problems in the United States, with 31% percent of the population considered obese. Previous studies have shown that there is a higher incidence of depression in people who are overweight. It is not known whether depression causes obesity or vice versa, but the association may stem from the stigma of obesity or from the appetite and weight gain caused by depressive symptoms. With the increased risk of cardiovascular and other life-threatening diseases from obesity, promotion of healthful habits is important. Providing the motivational skills to adhere to these habits is also crucial, especially in people who are both overweight and depressed. This study will compare the effectiveness of two weight loss programs, one supplemented with health education and the other supplemented with behavioral counseling, in treating women who are depressed and overweight.
Participants in this 2-year study will be divided into one of two treatment groups: one group will address weight loss and depression via nutrition, exercise, and health education and the other group will address weight loss and depression via nutrition, exercise, and behavioral counseling. Participants receiving health education will learn about women's health topics and receive tips on staying healthy and preventing disease. Participants receiving behavioral counseling will learn about depression and links between activity and mood. They will also be asked to keep a diary of moods and activities. Participants in both treatment groups will undergo the same schedule of study visits and assessments. A baseline visit will include blood tests; measurements of height, weight, waist size, and blood pressure; and completion of questionnaires about depression, eating habits, and physical activity. Next, over a 3-week period, participants will receive three phone calls asking about food intake from the previous day. In the first 6 months of the study, there will be a total of 26 weekly treatment visits. These visits will consist of ten 1-hour sessions with a counselor and sixteen 90-minute sessions with a dietician. During the next 6 months, participants will continue to meet with their dieticians monthly for a total of 6 visits and will receive monthly phone calls from their counselor. Quaterly phone calls with their counselor will continue in the second year of the study. There will be three check-in appointments similar to the baseline assessment, occurring at Month 6 and Years 1 and 2.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Massachusetts
-
Worcester, Massachusetts, États-Unis, 01655
- University of Massachusetts Medical School
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Meets DSM-IV criteria for major depressive disorder
- Score of 12 to 24 on Hamilton Depression Rating Scale (HDRS)
- Body mass index (BMI) of 30 to 40 kg
Exclusion Criteria:
- Plans to move out of the area during the study
- Current smoker
- Diagnosis of bipolar disorder, a psychotic disorder, bulimia, or post-traumatic stress disorder
- Meets criteria for severe depression (HDRS score greater than 24)
- Diagnosis of type 1 or 2 diabetes
- Plans to have bariatric surgery during the study
- No access to a telephone
- Unable to walk unaided or unable to walk 1/4 mile without stopping
- Does not have written clearance from primary care physician for physical activity
- Presence of a condition that precludes dietary changes (e.g., ulcerative colitis, Crohn's disease, active diverticulitis, renal disease)
- Presence of medical conditions likely to limit lifespan
- Taking prescription weight loss medications
- Initiation of anti-depressant medication within the 3 months prior to study entry
- Taking mood stabilizers, antipsychotic medication, or medications known to affect appetite and/or weight (e.g., corticosteroids)
- Reports active suicidal ideation via SCID interview, a score of 3 on item 24 of the HDRS (active suicidal ideation), or determined to have suicidal potential by clinical staff
- Psychiatric hospitalization in the 12 months prior to study entry
- Currently receiving psychotherapy
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
---|---|
Comparateur actif: 1
Evidence-based behavioral weight loss treatment with health education counseling
|
Over 2 years, this treatment involves a total of 26 group visits and 10 individual visits with a health education counselor.
Group visits, led by a registered dietitian and a licensed exercise physiologist, will target diet and physical activity.
Health education counseling will be delivered by a trained health education counselor.
Participants receiving health education will learn about women's health topics and receive tips on staying healthy and preventing disease.
|
Expérimental: 2
Evidence-based behavioral weight loss treatment with brief behavior therapy for depression
|
Over 2 years, this treatment involves a total of 26 group visits and 10 individual visits with a health education counselor.
Group visits, led by a registered dietitian and a licensed exercise physiologist, will target diet and physical activity.
Behavior therapy for depression will be delivered by a trained behavior therapist.
Participants receiving behavioral counseling will learn about depression, links between activity and mood, and will be asked to keep a diary of moods and activities.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Délai |
---|---|
Change in body weight and the trend in body weight over time
Délai: Measured at Month 6 and Years 1 and 2
|
Measured at Month 6 and Years 1 and 2
|
Mesures de résultats secondaires
Mesure des résultats |
Délai |
---|---|
Change in depression, physical activity, diet (daily caloric intake), psychosocial variables (anhedonia, exercise self-efficacy, disinhibited eating, quality of life), and cardiovascular risk factors (blood pressure, serum lipids, C-reactive protein)
Délai: Measured at Year 2
|
Measured at Year 2
|
Effect of potential mediators (adherence, depression, general and physical activity, caloric intake) on weight change
Délai: Measured at Year 2
|
Measured at Year 2
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Sherry L. Pagoto, PhD, University of Massachusetts, Worcester
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- R01MH078012 (Subvention/contrat des NIH des États-Unis)
- DAHBR 96-BHB
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Weight loss treatment
-
Columbia UniversityNeurolutions, Inc.RetiréAccident vasculaire cérébral | Hémiparésie
-
The Miriam HospitalComplétéObésité | En surpoidsÉtats-Unis
-
University of ConnecticutWeight Watchers InternationalComplétéSurpoids et obésité
-
Dartmouth-Hitchcock Medical CenterHitchcock FoundationComplétéLa dépression | ObésitéÉtats-Unis
-
University of AlbertaCanadian Institutes of Health Research (CIHR); Alberta Health services; Alberta...Complété
-
Tel-Aviv Sourasky Medical CenterComplétéInfertilité | Perte de sang vaginaleIsraël
-
University of BirminghamNational Institute for Health Research, United KingdomInconnueHypertension intracrânienne idiopathiqueRoyaume-Uni
-
University of North Carolina, Chapel HillWeight Watchers InternationalComplétéSurpoids et obésitéÉtats-Unis
-
University of ZurichActif, ne recrute pasHypertension artérielle pulmonaire | Hypertension pulmonaire thromboembolique chronique | Maladie vasculaire pulmonaireSuisse
-
University of British ColumbiaComplétéSurpoids et obésité | Régime cétogèneCanada